SNHG18 and hepatocellular carcinoma: Among HCC patients exhibiting AFP levels below 200 ng/mL, SNHG18 shows comparatively high sensitivity and specificity relative to cirrhosis patients and healthy controls, with sensitivity at 75.61% and specificity at 73.49% [122].